Article info

Download PDFPDF

Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn’s disease
Free

Authors

  • M F Neurath aI. Department of Medicine, University of Mainz, Langenbeckstrasse 1, 55101 Mainz, Germany, bDepartment of Medical Statistics, University of Mainz, Langenbeckstrasse 1, 55101 Mainz, Germany PubMed articlesGoogle scholar articles
  • R Wanitschke aI. Department of Medicine, University of Mainz, Langenbeckstrasse 1, 55101 Mainz, Germany, bDepartment of Medical Statistics, University of Mainz, Langenbeckstrasse 1, 55101 Mainz, Germany PubMed articlesGoogle scholar articles
  • M Peters aI. Department of Medicine, University of Mainz, Langenbeckstrasse 1, 55101 Mainz, Germany, bDepartment of Medical Statistics, University of Mainz, Langenbeckstrasse 1, 55101 Mainz, Germany PubMed articlesGoogle scholar articles
  • F Krummenauer aI. Department of Medicine, University of Mainz, Langenbeckstrasse 1, 55101 Mainz, Germany, bDepartment of Medical Statistics, University of Mainz, Langenbeckstrasse 1, 55101 Mainz, Germany PubMed articlesGoogle scholar articles
  • K-H Meyer zum Büschenfelde aI. Department of Medicine, University of Mainz, Langenbeckstrasse 1, 55101 Mainz, Germany, bDepartment of Medical Statistics, University of Mainz, Langenbeckstrasse 1, 55101 Mainz, Germany PubMed articlesGoogle scholar articles
  • J F Schlaak aI. Department of Medicine, University of Mainz, Langenbeckstrasse 1, 55101 Mainz, Germany, bDepartment of Medical Statistics, University of Mainz, Langenbeckstrasse 1, 55101 Mainz, Germany PubMed articlesGoogle scholar articles
  1. Dr Neurath.
View Full Text

Citation

Neurath MF, Wanitschke R, Peters M, et al
Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn’s disease

Publication history

  • Accepted December 8, 1998
  • First published May 1, 1999.
Online issue publication 
May 01, 1999

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.